ACHILLES THERAPEUTICS
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. The company's immunotherapies harness the immune system to destroy cancer cells that target truncal tumor neo-antigens and flags to the immune system present on the surface of every cancer cell, enabling scientists to target and destroy tumors without harming healthy tissues.
ACHILLES THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2016-05-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.achillestx.com
Total Employee:
101+
Status:
Active
Contact:
+44 (0)1438 906 906
Email Addresses:
[email protected]
Total Funding:
212.99 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Google Maps Content Delivery Network Amazon IPv6 ReCAPTCHA ReCAPTCHA V2 Shutterstock
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Bactolife
Bactolife helps in developing innovative solutions meeting the global need for reducing antimicrobial resistance.
Blueheart
Blueheart is the emerging category leader for digital therapeutics (DTx) for relationship strength.
Homage
Homage is a complete solution that combines technology and the best care professionals to enable seniors to age at home with dignity.
Inceptor Bio
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.
Ori Biotech
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.
Perci Health
Perci Health provides holistic care, telehealth, and wellness treatment for cancer diseases.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
T-knife
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.
Wyndly
Curing allergies from home
Current Employees Featured
Founder
Stock Details
Investors List
Horizon 2020
Horizon 2020 investment in Grant - Achilles Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Achilles Therapeutics
Redmile Group
Redmile Group investment in Series C - Achilles Therapeutics
Invus
Invus investment in Series C - Achilles Therapeutics
Boxer Capital
Boxer Capital investment in Series C - Achilles Therapeutics
OrbiMed
OrbiMed investment in Series C - Achilles Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - Achilles Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series C - Achilles Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series C - Achilles Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Achilles Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-30 | Achilles Therapeutics Appoints James Taylor as Chief Business Officer and Cassian Yee, MD to Scientific Advisory Board |
Official Site Inspections
http://www.achillestx.com Semrush global rank: 3.22 M Semrush visits lastest month: 4.56 K
- Host name: 4.234.1.245
- IP address: 4.234.1.245
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Achilles Therapeutics"
About Us | Achilles Therapeutics
About Achilles Therapeutics. Achilles Therapeutics is a biopharmaceutical company developing novel cancer immunotherapies targeting clonal neoantigens.See details»
Achilles Therapeutics - Crunchbase Company Profile & Funding
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. The company's immunotherapies harness the …See details»
Contact Us | Achilles Therapeutics
[email protected] +44 (0)20 8154 4600. Please do not send any personal patient details in emails. Investor Relations. [email protected]. Media Enquiries. [email protected]. UK …See details»
A c h i l l e s T h e r ap e u ti c s p l c
Apr 4, 2024 organization) (Primary Standard Industrial. Classification Code Number) Daniel C.C. Hood. Chief Legal Officer/General Counsel and Company. Secretary (I.R.S. Employer …See details»
Investor Relations | Achilles Therapeutics plc
US Headquarters: Achilles Therapeutics US, Inc. 401 N. Broad Street Suite M121 Philadelphia, PA 19108See details»
Achilles Therapeutics - Overview, News & Similar companies
Apr 4, 2024 Achilles Therapeutics contact info: Phone number: +44 2081544600 Website: www.achillestx.com What does Achilles Therapeutics do? Achilles Therapeutics is a …See details»
Achilles Therapeutics plc (ACHL) - Yahoo Finance
See the company profile for Achilles Therapeutics plc (ACHL) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Achilles Therapeutics plc - LinkedIn
Achilles Therapeutics plc Biotechnology Research Hammersmith, England 27,058 followers Personalised T cell therapies targeting clonal neoantigensSee details»
Achilles Therapeutics plc - Company Profile & Staff Directory
Achilles Therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells. The therapies will target truncal (also …See details»
ACHL Stock - Achilles Therapeutics plc
US Headquarters: Achilles Therapeutics US, Inc. 401 N. Broad Street Suite M121 Philadelphia, PA 19108See details»
Expanded Access Policy | Achilles Therapeutics
If you have additional questions, patients should speak with your treating physician. Physicians can contact Achilles Therapeutics via [email protected]. Home; About Us; Science; …See details»
Press Release - ir.achillestx.com
Aug 9, 2022 [email protected] LifeSci Advisors John Mullaly [email protected]. Media: Consilium Strategic Communications Mary-Jane Elliott, Sukaina Virji, Melissa Gardiner …See details»
ACHL Stock Price Quote | Morningstar
Nov 25, 2024 See the latest Achilles Therapeutics PLC ADR stock price (ACHL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
Science | Achilles Therapeutics
Achilles Therapeutics' scientific approach. Our Approach. During the process of transformation from a normal cell into a cancer cell, a cell acquires a series of changes, or mutations, in its DNA.See details»
Press Release - Achilles Therapeutics plc
Mar 1, 2022 [email protected]. LifeSci Advisors John Mullaly [email protected]. Media: Consilium Strategic Communications Mary-Jane Elliott, Sukaina Virdi, Melissa …See details»
Achilles International
Achilles International offers athletic programs and social connections for individuals with disabilities, promoting well-being and self-confidence.See details»
Achilles Therapeutics Reports Second Quarter 2024 Financial …
Aug 14, 2024 [email protected] : ACHILLES THERAPEUTICS PLC: Condensed Consolidated Balance Sheets (Unaudited) (in thousands, except share and per …See details»
Pipeline | Achilles Therapeutics
Achilles Pipeline. Our lead product is a precision tumor-derived T cell therapy targeting clonal cancer neoantigens. Our lead indications, advanced non-small cell lung cancer and recurrent …See details»
Press Release - Achilles Therapeutics plc
[email protected] . Julia Wilson – Head of Communications +44 (0)7818 430877 [email protected] . Consilium Strategic Communications Mary-Jane Elliott, Sukaina Virji, …See details»